Term
|
Definition
Any undesirable occurance related to administering or failing to administer a prescribed medication
|
|
|
Term
|
Definition
Any chemical that effects the physiological processes of a living organism. |
|
|
Term
|
Definition
Any unexpected, unintended, undesired, or excessive response to a medication given at therapeutic dosages (as exposed to overdose)
|
|
|
Term
|
Definition
Drug interactions in which the effect of a combination of two or more drugs with similar actions is equivalant to the sum of the individual effects of the same drugs given alone.
1 + 1 = 2 |
|
|
Term
|
Definition
a drug that binds to and stimulates the activity of one or more receptors in the body |
|
|
Term
|
Definition
an immunologic hypersensitivity reaction resulting from the unusually sensitivity of a patient to a particular medication; a type of adverse drug event |
|
|
Term
|
Definition
A drug that binds to and inhibits the activity of one or more receptors in the body; also called an inhibitor |
|
|
Term
|
Definition
drug interactions in which the effect of a combination of two or more drugs is less than the sum of individual effects of the same drugs given alone. Usually caused by a blocking or reducing effect of one drug on another |
|
|
Term
|
Definition
A measure of the extent of drug absorption for a given drug and route |
|
|
Term
|
Definition
one or more biochemical reactions involving a parent drug: occurs mainly in the liver and produces a metabolite that is either inactive or active |
|
|
Term
|
Definition
the barrier system that restricts the passage of various chemicals and microscopic entities between the blood stream and the central nervous system. Allows passage of the essential substances such as oxygen |
|
|
Term
|
Definition
The name that describes the chemical composition and molecular structure of a drug |
|
|
Term
|
Definition
Any condition; especially one related to a disease stare or other patient characteristic, including current or recent drug therapy that renders a particular form of treatment improper or undesirable |
|
|
Term
|
Definition
The general name for a large class of enzymes that play a significant role in drug metabolism. |
|
|
Term
|
Definition
a state in which there is a compulsive or chronic need for a drug |
|
|
Term
|
Definition
The process by which solid forms of drugs disintegrate into the gastrointestinal tract and become soluble before being absorbed into the circulation |
|
|
Term
|
Definition
the cellular processes involved in the interaction between a drug and body cells; also called mechanism of action |
|
|
Term
|
Definition
The physiological reactions of the body to a drug. They can be therapeutic or toxic and decide how the function of the body is affected as a whole by the drug. The terms onset, peak and duration are used to describe drug effects. |
|
|
Term
Drug induced teratogenisis: |
|
Definition
the development of congenital anomalies or defects in the developing fetus caused by the toxic effects of drugs |
|
|
Term
|
Definition
Alteration in the pharmacologic activity of a given drug caused by the presence of one or more additional drugs; it is usually related to the effects on the enzymes required for metabolism of the involved drugs |
|
|
Term
|
Definition
the length of time the concentration of a drug in the blood or tissues is sufficient to elicit a response |
|
|
Term
|
Definition
Protein molecules that catalyze one or more of a variety of biochemical reactions, including those related to the body’s own physiologic processes as well as those related to drug metabolism |
|
|
Term
|
Definition
The initial metabolism in the liver of a drug absorbed from the gastrointestinal tract before the drug reaches systemic circulation through the bloodstream |
|
|
Term
|
Definition
the name given to a drug by the United States Adopted Names Council. Also called the nonproprietary name. the generic name is much shorter and simpler than the chemical name and is not protected by trademark |
|
|
Term
|
Definition
In pharmokinetics, the time required for half of an administered dose of a drug to be eliminated from the body, or the time it takes for the blood level of a drug to be reduced by 50% |
|
|
Term
|
Definition
An abnormal and unexpected response to a medication, other than an allergic reaction, that is peculiar to and individual patient |
|
|
Term
|
Definition
the characteristic that causes two parenteral drugs or solutions to undergo a reaction when mixed or given together that results in the chemical deterioration of at least one of |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
any preventable adverse drug event involving inappropriate medication use by a patient or healthcare professional; may or may not cause patient harm |
|
|
Term
Medication use processes: |
|
Definition
the prescribing, dispensing and administering of medications, and the monitoring of their effects |
|
|
Term
|
Definition
a chemical form of a drug that is the product of one or more biochemical (metabolic) reactions involving the parent drug. Active metabolites are those that have pharmacologic activity of their own, even if the parent drug is inactive. Inactive metabolites lack pharmacological activity and are simply drug waste products awaiting excretion from the body |
|
|
Term
|
Definition
the time required for a drug to elicit a therapeutic response after dosing |
|
|
Term
|
Definition
the chemical form of a drug that is administered before it is metabolized by the body’s biochemical reactions into is active or inactive metabolites. A parent drug that is not pharmacologically active itself is called a prodrug. A prodrug is then metabolized to pharmacologically active metabolites |
|
|
Term
|
Definition
the time required for a drug to reach its maximum therapeutic responses in the body |
|
|
Term
|
Definition
the maximum concentration of a drug in the body after administration, usually measured in a blood sample for therapeutic drug monitoring |
|
|
Term
|
Definition
the science of preparing and dispensing drugs, including dosage from design |
|
|
Term
|
Definition
the study of the biochemical and physiologic interactions of drugs at there sites of activity. It examines the physicochemical properties of drugs and their pharmacologic interactions with body receptors |
|
|
Term
|
Definition
the study of the influence of genetic factors on drug responses, including the nature of genetic aberrations that result in the absence, overabundance, or insufficiency of drug-metabolizing enzymes |
|
|
Term
|
Definition
the study of drugs that are obtained from natural plant and animal sources |
|
|
Term
|
Definition
the rate of drug distribution among various body compartments after a drug has entered the body. It includes the phases of absorption, distribution, metabolism, and excretion of drugs |
|
|
Term
|
Definition
the broadest term for the study or the science of drugs |
|
|
Term
|
Definition
the treatment of pathologic conditions through the use of drugs |
|
|
Term
|
Definition
an inactive drug dosage form that is converted to an active metabolite by various biochemical reactions once its inside the body |
|
|
Term
|
Definition
A molecular structure within or on the outer surface of a cell. Receptors bind specific substances and one or more corresponding cellular effects occurs as a result of this drug-receptor interaction |
|
|
Term
|
Definition
the physiologic state in which the amount of drug removed via elimination is equal to the amount of drug absorbed with each dose |
|
|
Term
|
Definition
substances on which enzymes act |
|
|
Term
|
Definition
drug interactions in which the effect of a combination of two or more drugs with similar actions is greater than the sum of individual effects of the same drugs given alone |
|
|
Term
Therapeutic drug monitoring |
|
Definition
the process of measuring drug peak and trough levels to gauge the level of a patient’s drug exposure and allow adjustment of dosages with the goals of maximizing therapeutic effects and minimizing toxicity |
|
|
Term
|
Definition
the desired or intended effect of a particular medication |
|
|
Term
|
Definition
the ratio between the toxic and therapeutic concentrations of a drug |
|
|
Term
|
Definition
reduced response to a drug after prolonged use |
|
|
Term
|
Definition
the quality of being poisonous |
|
|
Term
|
Definition
the condition of producing adverse bodily effects due to poisonous qualities |
|
|
Term
|
Definition
the study of poisons, including toxic drug effects, and applicable treatments |
|
|
Term
|
Definition
the commercial name given to a drug product by its manufacture; also called the proprietary name |
|
|
Term
|
Definition
the lowest concentration of drug reached in the body after it falls from its peak level, usually measured in a blood sample for therapeutic drug monitoring |
|
|